Koo S-Y, Park E-J, Lee C-W. Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma. Exp Mol Med. 2020;52(8):1209–19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rabiu L, Zhang P, Afolabi LO, et al. Immunological dynamics in MASH: from landscape analysis to therapeutic intervention. J Gastroenterol. 2024. https://doi.org/10.1007/s00535-024-02157-0. PMID: 39400718.

Article  PubMed  Google Scholar 

Friedman SL, Neuschwander-Tetri BA, Rinella M, et al. Mechanisms of NAFLD development and therapeutic strategies. Nat Med. 2018;24(7):908–22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

FDA approves first MASH drug. Nat Biotechnol. 2024;42(4):540. https://doi.org/10.1038/s41587-024-02220-4.

Liver EAftSot D, EAftSo O, EAftSo. EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). Obes Facts. 2024;17(4):374–444.

Article  Google Scholar 

Bieghs V, Trautwein C. The innate immune response during liver inflammation and metabolic disease. Trends Immunol. 2013;34(9):446–52. https://doi.org/10.1016/j.it.2013.04.005. Epub 20130511.

Article  CAS  PubMed  Google Scholar 

Liu Y, Song J, Yang J, et al. Tumor necrosis factor α–Induced protein 8–Like 2 alleviates nonalcoholic fatty liver disease through suppressing transforming growth factor Beta–Activated kinase 1 activation. Hepatology. 2021;74(3):1300–18.

Article  CAS  PubMed  Google Scholar 

Sun H, Gong S, Carmody RJ, et al. TIPE2, a negative regulator of innate and adaptive immunity that maintains immune homeostasis. Cell. 2008;133(3):415–26.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang H, Zhu T, Liu W, et al. TIPE2 acts as a negative regulator linking NOD2 and inflammatory responses in myocardial ischemia/reperfusion injury. J Mol Med. 2015;93:1033–43.

Article  CAS  PubMed  Google Scholar 

Tao Y, Zhao J, Yin J, et al. Hepatocyte TIPE2 is a fasting-induced Raf-1 inactivator that drives hepatic gluconeogenesis to maintain glucose homeostasis. Metabolism. 2023;148:155690. https://doi.org/10.1016/j.metabol.2023.155690. Epub 20230916.

Article  CAS  PubMed  Google Scholar 

Lu D, Yang Z, Xia Q, et al. ACADSB regulates ferroptosis and affects the migration, invasion, and proliferation of colorectal cancer cells. Cell Biol Int. 2020;44(11):2334–43.

Article  CAS  PubMed  Google Scholar 

Yarahmadi S, Abdolvahabi Z, Hesari Z, et al. Inhibition of Sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene. 2019;711:143939.

Article  CAS  PubMed  Google Scholar 

Gallage S, Avila JEB, Ramadori P, et al. A researcher’s guide to preclinical mouse NASH models. Nat Metabolism. 2022;4(12):1632–49.

Article  CAS  Google Scholar 

Liu L, Liu C, Zhao M, et al. The pharmacodynamic and differential gene expression analysis of PPAR Α/δ agonist GFT505 in CDAHFD-induced NASH model. PLoS ONE. 2020;15(12):e0243911.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung Y, Zhao M, Svensson KJ. Isolation, culture, and functional analysis of hepatocytes from mice with fatty liver disease. STAR Protoc. 2020;1(3):100222. https://doi.org/10.1016/j.xpro.2020.100222. Epub 20201215.

Article  PubMed  PubMed Central  Google Scholar 

Schaffer S, Maul-Pavicic A, Voll RE, et al. Optimized isolation of renal plasma cells for flow cytometric analysis. J Immunol Methods. 2019;474:112628. https://doi.org/10.1016/j.jim.2019.06.019. Epub 20190626.

Article  CAS  PubMed  Google Scholar 

Autengruber A, Gereke M, Hansen G, et al. Impact of enzymatic tissue disintegration on the level of surface molecule expression and immune cell function. Eur J Microbiol Immunol (Bp). 2012;2(2):112–20. https://doi.org/10.1556/EuJMI.2.2012.2.3. Epub 20120613.

Article  CAS  PubMed  Google Scholar 

Li Y, Zhang N, Ma C, et al. The overexpression of Tipe2 in CRC cells suppresses survival while endogenous Tipe2 accelerates AOM/DSS induced-tumor initiation. Cell Death Dis. 2021;12(11):1001. https://doi.org/10.1038/s41419-021-04289-0.

Article  PubMed  PubMed Central  Google Scholar 

Vily-Petit J, Soty-Roca M, Silva M, et al. Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. Gut. 2020;69(12):2193–202. https://doi.org/10.1136/gutjnl-2019-319745. Epub 20200323.

Article  CAS  PubMed  Google Scholar 

Dickson I. Intestinal gluconeogenesis prevents hepatic steatosis. Nat Reviews Gastroenterol Hepatol. 2020;17(6):316. https://doi.org/10.1038/s41575-020-0301-0.

Article  Google Scholar 

Yang M, Ma F, Guan M. Role of steroid hormones in the pathogenesis of nonalcoholic fatty liver disease. Metabolites. 2021. https://doi.org/10.3390/metabo11050320. PubMed PMID: 34067649; PubMed Central PMCID: PMC8156407.

Article  PubMed  PubMed Central  Google Scholar 

Jia X, Zhang X, Yan M, et al. Increased TG to HDL-C ratio is associated with severity of drug-induced liver injury. Sci Rep. 2023;13(1):6897. https://doi.org/10.1038/s41598-023-34137-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang S, Du T, Zhang J, et al. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease. Lipids Health Dis. 2017;16(1):15. https://doi.org/10.1186/s12944-017-0409-6. Epub 20170119.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Darmadi D, Ruslie RH. Association between serum Interleukin (IL)-12 level and severity of non-alcoholic fatty liver disease (NAFLD). Rom J Intern Med. 2021;59(1):66–72. https://doi.org/10.2478/rjim-2020-0029. Epub 2020/10/16.

Article  PubMed  Google Scholar 

Friedline RH, Noh HL, Suk S, et al. IFNγ-IL12 axis regulates intercellular crosstalk in metabolic dysfunction-associated steatotic liver disease. Nat Commun. 2024;15(1):5506. https://doi.org/10.1038/s41467-024-49633-y. Epub 2024/07/02.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eskridge W, Cryer DR, Schattenberg JM, et al. Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective. J Clin Med. 2023;12(19):6216.

Article  PubMed  PubMed Central  Google Scholar 

Shao T, Chen YL. Stop using the misidentified cell line LO2 as a human hepatocyte. J Hepatol. 2024;80(5):e200–1. https://doi.org/10.1016/j.jhep.2023.10.036. Epub 20231110.

Article  PubMed  Google Scholar 

Lu Y, Cederbaum AI. CYP2E1 and oxidative liver injury by alcohol. Free Radic Biol Med. 2008;44(5):723–38. https://doi.org/10.1016/j.freeradbiomed.2007.11.004. Epub 20071117.

Article  CAS  PubMed  Google Scholar 

Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103–41. https://doi.org/10.1016/j.pharmthera.2012.12.007. Epub 20130116.

Article  CAS  PubMed  Google Scholar 

Zaganjor E, Spinelli JB, Haigis MC. Strength in numbers: phosphofructokinase polymerization prevails in the liver. J Cell Biol. 2017;216(8):2239–41. Epub 20170717. doi: 10.1083/jcb.201706005. PubMed PMID: 28716843; PubMed Central PMCID: PMC5551721.

Article  CAS  PubMed  PubMed Central